CVS ın multıple pregnancıes

The frequency of multiple pregnancies is about 2% of all gestation. While monozygotic pregnancies are relatively constant in number, multizygotic multiples reveal an increased rate in recent years, due to the widespread use of infertility treatments.
The aged maternal age at pregnancy, some genetic indications related to infertility problems, and the increased individual risk of aneuploidies in women carrying multiples, lead to an increased demand for invasive prenatal diagnosis in these pregnancies. Ultrasound screening by first trimester nuchal translucency, can indicate in multiple pregnancies, cases at higher risk for aneuploidies.
The development of ultrasound equipments allows less traumatic access to obtain fetal and placental tissues, reduction of procedure- related risks, and earlier sampling. At the same time, great developments of laboratory techniques in prenatal diagnosis of mendelian and chromosomal diseases has given greater opportunities for diagnostic accuracy. In multiple pregnancies, before genetic counselling, a very accurate ultrasound examination to establish the chorionicity, is mandatory. The lambda-sign at 10- 14 weeks indicates dichorionic placentation, while the T- sign is suggestive of monochorionic diamniotic pregnancy. Ultrasound examination of chorionicity is highly indicative at first trimester ultrasound, but it become less accurate at second trimester scan.
During the genetic counselling, the assessment of the genetic risk, the possibility to perform a further or different sampling (first trimester chorionic villi sampling and second trimester amniocentesis), the likelihood of sampling all the sacs, the accuracy of genetic analysis (sampling contamination, false positives, false negatives, misdiagnosis), the eventuality of one abnormal fetus and therapeutic options (selective fetocide), and the risk of early and late pregnancy loss related to the procedure, are the issues to be discussed.
Chorionic villi sampling (CVS) is the technique of choice for diagnosis of beta-thalassemia and other monogenic diseases at first and second trimester, while for karyotype analysis, CVS and amniocentesis are the procedures most frequently performed.
First trimester CVS can be performed either transcervically (by catheter or rigid biopsy forceps) or transabdominally (by double coaxial needle or by single needle) and in a few cases by the two techniques combined.
The transabdominal free- hand CVS technique is performed using a 20 gauge spinal needle connected to a syringe for aspiration under continue ultrasonic monitoring. Second trimester CVS is performed only by transabdominal approach, using 19 gauge from13 to 15 weeks, and 18 gauge spinal needle after 15 weeks.
A very accurate ultrasound examination should be carried out before invasive procedure to evaluate vitality, gestational age, number of fetuses, chorionicity and presence of fetal malformations.
Multiple sagittal and trasverse scanning plane should be carried out in order to obtain a three dimensional map of the uterine content and relationship with the maternal surface.
The placental position and umbilical cord insertions must be identified. In multichorionic pregnancies, all placentas should be sampled by separated needles. In monochorionic placentas, a single sample could be taken, but also two samples are indicated (samples obtained from a point in the placenta very close to the cord insertion). Fetal loss following CVS in multiples is the same as reported for second trimester amniocentesis in multiples (2- 3%). Sampling success is very high in expert hands and large series (>98%).
In the case of like- sex results or concordant genetic results, chromosome polymorphism and DNA analysis or highly variable polymorphic sites studies should be more informative. The risk of entire pregnancy loss following selective fetocide in cases of one or more fetuses resulting abnormal is higher if termination is performed in the second trimester than in the first trimester.
First trimester CVS is the technique of choice in multiple pregnancies at high genetic risk, since the earlier diagnosis offers an advantage in cases of selective termination.
Prenatal diagnosis in multiple pregnancies is safe and accurate, but obstetric risks and diagnostic errors are likely to be increased and great skill and experience are requested.
It is indicated to perform multiple pregnancy sampling and analysis for prenatal diagnosis in centers of large expertise.

Anahtar Kelimeler

Kaynaklar
1.Berkowitz RL, Lynch L, Chitkara U, Wilkins IA, Mahalek KE, Alvarez E. Selective reduction of multifetal pregnancies in the first trimester. N Engl J Med 1988;318:1043-7
2.Chervenak FA, Youcha S, Johnson RE, Berkowitz RL, Hobbins JC. Twin gestation. Antenatal diagnosis ans perinatal outcome in a series of 385 consecutive pregnancies. J Repro Med 1984;29:727-30
3.D'Alton ME, Dudley DK. The ultrasonographic prediction of chorionicity in twin gestation. Am J Obstet Gynecol 1989; 160:557-61
4.Guttmacher AF. The incidence of multiple births in man and some other unipara. Obstet Gynecol 1953;2:22-35
5.Hill AVSS, Jeffreys AJ. Use of minisatellite DNA probes for determination of twin zygosity at birth. Lancet 1985;2:1394-5
6.Mahony BS, Filly RA, Callen PW. Amnionicity and chorionicity in twin pregnancies: prediction using ultrasound. Radiology 1985;155:205-9
7.Monteagudo A, Timor-Tritsch IE, Sharma S. Early and simple determination of chorionic and amniotic type in multifetal gestation in the first fourteen weeks by high frequency transvaginal ultrasonography. Am J Obstet Gynecol 1994;170:824-9
8.Monni G, Rosatelli C, Falchi AM, et al. First trimester diagnosis of beta-thalassemia in a twin pregnancy. Prenat Diagn 1986;6:63-8
9.Monni G, Ibba RM, Lai R, Cau G, Mura S, Olla G, Rosatelli C, Cao A (1993): Early Transabdominal chorionic villus sampling in couples at high genetic risk. Am J Obstet Gynecol. 168(1 Pt 1): 170-3.
10.Monni G, Ibba RM, Zoppi MA, Şoris M (1997): Prenatal diagnosis in multiple pregnancies. Abstracts on 13th International Congress "The Fetus as aPatient", Basilea. Fetal Diagn Ther, 12:119- 20
11.Monni G, Ibba RM. Invasive procedures in multiple pregnancies. In : Weiner S, Kurjak A, editors. Interventional Ultrasound. New York- London: The Parthenon Publishing Group; 1999. p 105- 15
12.Monni G, Zoppi MA, Ibba RM, Putzolu M, Şoris M. Nuchal translucency in multiple pregnancies. Croat Med J. 2000; 41: 266- 9.
13.National Center for Health Statistics. Vital statistics of the United States, 1988. In Natality, Vol. 1. Washington, DC: US Government Printing Office, 1990
14.Pandya PP, Hilbert F, Snijders RJM, Nicolaides KH. Nuchal translucency thickness and crown- rump length in twin pregnancies with chromosomally abnormal fetuses. J Ultrasound Med 1995; 14: 565- 8
15.Pergament E, Schulman J, Copeland K, et al. The risk and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn 1992; 12:377-84
16.Rodis JF, Egan JF, Craffey A, Ciarleglio L, Greestein RN, Scorza WE. Calculated risk of chromosomal abnormalities in twin gestations. Obstet Gynecol 1990; 76:1037-41
17.Rogers JG, Voullaire L, Gold H. Monozygotic twins discordant for trisomy 21. Am J Med Gemellol 1982; 11:143-6 18.Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10- 14 weeks of gestation. Br J Obstet Gynaecol 1996; 103: 999-1003
19.Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol. 1996;7: 421- 3.
20.Townsend RR, Simpson GF, Filly RA. Membrane thickness in ultrasound prediction of chorionicity of twin gestations. J Ultrasound Med 1988;7:327-32
21.Wapner RJ, Johnson A, Davis G. Prenatal diagnosis in twin gestations: a comparison between second trimester amniocentesis and first trimester chorionic villus sampling. Obstet Gynecol 1993;82:49-56
22.Wapner RJ. Genetic Diagnosis in multiple pregnancies. Sem Perinat 1995; 19: 351-62